NASDAQ
Cocrystal Pharma, Inc. (COCP) has a free cash flow growth of -34.79% as of Friday, May 29, 2026. This represents a 378.19% decrease compared to its 12-month average of 12.51%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.